Reviewed,
UniProtKB/Swiss-Prot Q7L8A9 (VASH1_HUMAN)
Last modified
November 25, 2008.
Version 35.
History...
Clusters with 100%,
90%,
50% identity |
Documents (4) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Vasohibin-1 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 365 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is not processed. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Angiogenesis inhibitor. Inhibits migration, proliferation and network formation by endothelial cells as well as angiogenesis. This inhibitory effect is selective to endothelial cells as it does not affect the migration of smooth muscle cells or fibroblasts. Does not affect the proliferation of cancer cells in vitro, but inhibits tumor growth and tumor angiogenesis. Acts in an autocrine manner. Inhibits artery neointimal formation and macrophage infiltration. Exhibits heparin-binding activity. |
| Subcellular location | |
| Tissue specificity | Preferentially expressed in endothelial cells. Highly expressed in fetal organs. Expressed in brain and placenta, and at lower level in heart and kidney. Highly detected in microvessels endothelial cells of atherosclerotic lesions. |
| Induction | By VEGF. |
| Post-translational modification | 2 major forms (42 and 36 kDa) and 2 minors (32 and 27 kDa) may be processed by proteolytic cleavage. The largest form (42 kDa) seems to be secreted and the other major form (63 kDa) seems to accumulate within the cells or pericellular milieu. Polypeptide consisting of Met-77 to Arg-318 may correspond to the 27 kDa form and that consisting of Met-77 to Val-365 may correspond to the 36 kDa form. |
| Sequence similarities | Belongs to the vasohibin family. |
| Caution | Although probably secreted, it lacks a canonical signal sequence. |
| Sequence caution | The sequence AAD44361.1 differs from that shown. Reason: Erroneous gene model prediction. |
Ontologies
Keywords | |
|---|---|
| Biological process | Cell cycle Growth arrest |
| Cellular component | Secreted |
| Coding sequence diversity | Alternative splicing |
Gene Ontology (GO) | |
| Biological process | cell cycle arrest Inferred from electronic annotation. Source: UniProtKB-KW negative regulation of angiogenesis Ref.5Inferred from direct assay. Source: UniProtKB negative regulation of blood vessel endothelial cell migration Ref.5Inferred from direct assay. Source: UniProtKB negative regulation of endothelial cell proliferation Ref.5Inferred from direct assay. Source: UniProtKB |
| Cellular component | endoplasmic reticulum Ref.5 Inferred from direct assay. Source: UniProtKB extracellular space Ref.5Inferred from direct assay. Source: UniProtKB nucleusInferred from direct assay. Source: HPA |
| Complete GO annotation... | |
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q7L8A9-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q7L8A9-2) The sequence of this isoform differs from the canonical sequence as follows: 177-204: IYLTNSMPTLERFPISFKTYFSGNYFRH → MYPSSPEGEGSGLLWASASCSESEGGVG 205-365: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 365 | 365 | Vasohibin-1 | PRO_0000189980 | |||||
Regions | |||||||||
| Region | 319 – 365 | 47 | Involved in heparin-binding and antiangiogenic activity | ||||||
Sites | |||||||||
| Site | 29 – 30 | 2 | Cleavage Probable | ||||||
| Site | 76 – 77 | 2 | Cleavage Probable | ||||||
Natural variations | |||||||||
| Alternative sequence | 177 – 204 | 28 | IYLTN…NYFRH → MYPSSPEGEGSGLLWASASC SESEGGVG in isoform 2. | VSP_013324 | |||||
| Alternative sequence | 205 – 365 | 161 | Missing in isoform 2. | VSP_013325 | |||||
Experimental info | |||||||||
| Mutagenesis | 29 | 1 | R → A: Disappearance of 42 kDa processed form | ||||||
| Mutagenesis | 76 | 1 | R → A: Disappearance of 36, 32 and 27 kDa processed forms | ||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Prediction of the coding sequences of unidentified human genes. XIV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro." Kikuno R., Nagase T., Ishikawa K., Hirosawa M., Miyajima N., Tanaka A., Kotani H., Nomura N., Ohara O. DNA Res. 6:197-205(1999) [PubMed: 10470851] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Brain. |
| [2] | The German cDNA consortium Submitted (JUN-2003) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Spinal cord. |
| [3] | "The DNA sequence and analysis of human chromosome 14." Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C., Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A., Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S., Sun H., Du H. Weissenbach J.Nature 421:601-607(2003) [PubMed: 12508121] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [4] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2). Tissue: Brain. |
| [5] | "Vasohibin as an endothelium-derived negative feedback regulator of angiogenesis." Watanabe K., Hasegawa Y., Yamashita H., Shimizu K., Ding Y., Abe M., Ohta H., Imagawa K., Hojo K., Maki H., Sonoda H., Sato Y. J. Clin. Invest. 114:898-907(2004) [PubMed: 15467828] [Abstract] Cited for: FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, INDUCTION. |
| [6] | "Gene regulation of a novel angiogenesis inhibitor, vasohibin, in endothelial cells." Shimizu K., Watanabe K., Yamashita H., Abe M., Yoshimatsu H., Ohta H., Sonoda H., Sato Y. Biochem. Biophys. Res. Commun. 327:700-706(2005) [PubMed: 15649403] [Abstract] Cited for: ALTERNATIVE SPLICING, INDUCTION. |
| [7] | "Multiple processing forms and their biological activities of a novel angiogenesis inhibitor vasohibin." Sonoda H., Ohta H., Watanabe K., Yamashita H., Kimura H., Sato Y. Biochem. Biophys. Res. Commun. 342:640-646(2006) [PubMed: 16488400] [Abstract] Cited for: FUNCTION, CLEAVAGE SITE, REGION, MUTAGENESIS OF ARG-29 AND ARG-76. |
| [8] | "Vasohibin prevents arterial neointimal formation through angiogenesis inhibition." Yamashita H., Abe M., Watanabe K., Shimizu K., Moriya T., Sato A., Satomi S., Ohta H., Sonoda H., Sato Y. Biochem. Biophys. Res. Commun. 345:919-925(2006) [PubMed: 16707096] [Abstract] Cited for: FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| AB028959 mRNA. Translation: BAA82988.2. Different initiation. AL832588 mRNA. Translation: CAD89941.1. AC007376 Genomic DNA. Translation: AAF02829.1. AF111169 Genomic DNA. Translation: AAD44361.1. Sequence problems. BC009031 mRNA. Translation: AAH09031.1. BC051896 mRNA. Translation: AAH51896.1. | |
| RefSeq | NP_055724.1. |
| UniGene | Hs.525479 |
3D structure databases | |
| ModBase | Search... |
PTM databases | |
| PhosphoSite | Q7L8A9. |
Genome annotation databases | |
| Ensembl | ENSG00000071246. Homo sapiens. [Contig view] |
| GeneID | 22846. |
| KEGG | hsa:22846. |
Organism-specific databases | |
| H-InvDB | HIX0011836. |
| HGNC | HGNC:19964. VASH1. |
| HPA | HPA000653. |
| MIM | 609011. gene. |
| PharmGKB | PA134941450. |
| HUGE | Search... |
| GenAtlas | Search... |
| GeneCards | Search... |
Phylogenomic databases | |
| HOVERGEN | Q7L8A9. |
Gene expression databases | |
| ArrayExpress | Q7L8A9. |
| CleanEx | HS_VASH1. |
| GermOnline | ENSG00000071246. Homo sapiens. |
Family and domain databases | |
| ProtoNet | Search... |
Other Resources | |
| NextBio | 43305. |
| SOURCE | Search... |
Entry information
| Entry name | VASH1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q7L8A9 Secondary accession number(s): Q96H02, Q9UBF4, Q9Y629 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
Relevant documents
| Human chromosome 14 Human chromosome 14: entries, gene names and cross-references to MIM |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| UniProtKB secondary accession numbers Index of UniProtKB secondary accession numbers |
| SIMILARITY comments Index of protein domains and families |

Clusters with


